基本资料 投资组合 财务数据 基金公告
汇添富纳斯达克生物科技ETF(QDII)(513290) |
净值：
1.1688
|
日增长率：
0.03%
|
累计净值：1.1688 | 2025-07-29 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| GILD | 吉利德科学 | 126,232.00 | 100,187,054.10 | 7.85 |
| VRTX | 福泰制药 | 31,435.00 | 100,183,619.11 | 7.85 |
| AMGN | 安进 | 48,219.00 | 96,377,856.73 | 7.55 |
| REGN | 再生元制药 | 21,127.00 | 79,400,864.66 | 6.22 |
| AZN | 阿斯利康(US ADR) | 118,625.00 | 59,341,322.08 | 4.65 |
| ALNY | Alnylam Pharmaceuticals Inc | 22,813.00 | 53,253,478.05 | 4.17 |
| BIIB | 生化基因 | 29,430.00 | 26,458,999.53 | 2.07 |
| INSM | Insmed Inc | 36,582.00 | 26,355,191.10 | 2.07 |
| ARGX | argenx SE ADR | 6,335.00 | 24,997,678.72 | 1.96 |
| SMMT | Summit Therapeutics Inc | 149,162.00 | 22,722,594.46 | 1.78 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2025-06-30 | 85.33 | - | 0.68 | 1,276,255,394.75 |
| 2025-03-31 | 86.03 | - | 0.63 | 1,345,089,030.94 |
| 2024-12-31 | 87.93 | - | 0.91 | 1,527,169,600.76 |
| 2024-09-30 | 87.03 | - | 0.96 | 1,360,481,855.81 |
| 2024-06-30 | 89.18 | - | 0.72 | 806,052,940.10 |
微信公众号
证券之星APP
